The week of May 14–21, 2026, witnessed a dramatic escalation of the Bundibugyo Ebola virus disease outbreak in the Democratic Republic of the Congo and Uganda, prompting the World Health Organization to declare a Public Health Emergency of International Concern (PHEIC) on May 17. As of May 20, the outbreak has resulted in 139 deaths and nearly 600 suspected cases, with confirmed cases spread across Ituri Province in DRC and cross-border into Uganda. The Bundibugyo strain, distinct from the more common Zaire ebolavirus, has no approved vaccines or specific therapeutics, severely complicating response efforts.

The WHO is urgently evaluating experimental medical countermeasures, including ring vaccination with candidate vaccines, but officials indicate that deployment or clinical trials may take six to nine months. The United States pledged funding for 50 Ebola treatment clinics in Ituri, while the CDC issued multiple Health Alert Network advisories and confirmed the evacuation of an exposed American healthcare worker to Germany. Africa CDC declared a Public Health Emergency of Continental Security (PHECS) and activated its Incident Management Support Team.

On-the-ground reports highlight critical shortages of personal protective equipment, isolation capacity, and healthcare worker infections, exacerbated by ongoing armed conflict in affected areas. The outbreak has also disrupted maternal health services, with 15 facilities closed and a 40% drop in safe deliveries. International aid funding cuts and regional insecurity further hamper containment, prompting African leaders to push for increased domestic financing and health sovereignty.

The ECDC assessed the risk to EU member states as low but urged vigilance for imported cases. This week's developments underscore the urgent need for broad-spectrum filovirus countermeasures and sustained global coordination to prevent a larger catastrophe.